Table 1.
Demographics and clinical assessments in the combined patient and control samples
| Schizophrenia (n = 58) | Healthy controls (n = 34) | F or χ 2 statistic | p -value | |
|---|---|---|---|---|
| Age (years) | 36.13 (14.33) | 35.26 (14.03) | 0.08 | 0.78 |
| Sex (male/female) | 41/17 | 20/14 | 1.35 | 0.26 |
| Smoker/nonsmoker | 19/39 | 7/27 | 1.57 | 0.24 |
| BPRS total score | 33.58 (9.63) | n/a | n/a | n/a |
| BPRS-positive symptoms | 7.37 (4.09) | n/a | n/a | n/a |
| Age of onset (years) | 19.85 ± 5.9 | n/a | n/a | n/a |
| Metabolic syndrome (%) | 21(36%) | 4 (12%) | 6.01 | 0.01 |
| Estradiol levels | 32.51 (35.61) | 32.81 (40.12) | 0.001 | 0.97 |
| Progesterone levels | 0.56 (0.36) | 0.56 (0.32) | 0.00 | 0.99 |
| Allostatic load | 5.15 (2.89) | 3.18 (2.26) | 15.65 | < 0.001 |
Data were given in mean (standard deviation); BPRSbrief psychiatric rating scale; statistics for AL include age and sex as covariates